According to Helen, the results of the independent review will be included in the 1/2 year results, due 29 Feb.
Here is an excerpt from her response:
"The next announcement is the half year results release which is due by 29 February. At that point the Board will have drawn together the results of both the strategic plan, as well as attached expenditure and associated cashflow for the proposed scientific activities which will be based on the recommendations of the scientific review which is in its final phases. A very full and frank communication will then be able to be made to shareholders, based on the extensive information gathered."
CBZ Price at posting:
8.8¢ Sentiment: Buy Disclosure: Held
